The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer
NCT00819247
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
129
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Degarelix
Sponsor
Ferring Pharmaceuticals